HIGHLAND CAPITAL MANAGEMENT LP - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 45 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.0%.

Quarter-by-quarter ownership
HIGHLAND CAPITAL MANAGEMENT LP ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$894,000
-8.4%
545,0000.0%0.05%
-14.8%
Q1 2019$976,000
+927.4%
545,000
+990.0%
0.06%
+771.4%
Q4 2018$95,00050,0000.01%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$42,747,00027.52%
ESSEX INVESTMENT MANAGEMENT CO LLC 637,696$650,0000.13%
Integrated Advisors Network LLC 478,630$488,0000.10%
BARD ASSOCIATES INC 79,400$81,0000.06%
Kore Private Wealth LLC 202,366$206,0000.05%
HighTower Advisors, LLC 5,284,688$5,390,0000.04%
NEXPOINT ASSET MANAGEMENT, L.P. 158,520$162,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 509,200$519,0000.01%
Summit X, LLC 25,500$26,0000.01%
American Portfolios Advisors 111,687$113,9210.01%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders